Synthesis, cytotoxicity against human oral cancer KB cells and structure-activity relationship studies of trienone analogues of curcuminoids

被引:42
作者
Chuprajob, Thipphawan [1 ,2 ]
Changtam, Chatchawan [3 ]
Chokchaisiri, Ratchanaporn [4 ]
Chunglok, Warangkana [5 ]
Sornkaew, Nilubon [1 ,2 ]
Suksamrarn, Apichart [1 ,2 ]
机构
[1] Ramkhamhang Univ, Fac Sci, Dept Chem, Bangkok 10240, Thailand
[2] Ramkhamhang Univ, Fac Sci, Ctr Excellence Innovat Chem, Bangkok 10240, Thailand
[3] Huachiew Chalermprakiet Univ, Fac Sci & Technol, Div Phys Sci, Samut Prakan 10540, Thailand
[4] Univ Phayao, Sch Sci, Dept Chem, Phayao 56000, Thailand
[5] Walailak Univ, Sch Allied Hlth Sci & Publ Hlth, Nakhon Si Thammarat 80160, Thailand
关键词
Curcuminoid; Trienone analogue; Synthesis; Cytotoxicity; KB; NITRIC-OXIDE SYNTHASE; IN-VIVO; INHIBITION; POTENT; HEAD; NECK; DIARYLHEPTANOIDS; CARCINOMA; RADIATION; ANTITUMOR;
D O I
10.1016/j.bmcl.2014.04.105
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A general method for the synthesis of substituted (1E,4E,6E)-1,7-diphenylhepta-1,4,6-trien-3-ones, based on the aldol condensations of substituted 4-phenylbut-3-en-2-ones and substituted 3-phenylacrylaldehydes, was achieved. The natural trienones 4 and 5 have been synthesized by this method, together with the trienone analogues 9-20. These analogues were evaluated for their cytotoxic activity against human oral cancer KB cell line. The structure-activity relationship study has indicated that the analogues with the 1,4,6-trien-3-one function are more potent than the curcuminoid-type function. Analogues with meta-oxygen function on the aromatic rings are more potent than those in the ortho- and para-positions. Free phenolic hydroxy group is more potent than the corresponding methyl ether analogues. Among the potent trienones, compounds 11, 18 and 20 were more active than the anticancer drug ellipticine. All compounds were also evaluated against the non-cancerous Vero cells and it was found that compounds 11, 12 and 17 were much less toxic than curcumin (1); they showed high selectivity indices of 35.46, 33.46 and 31.68, respectively. These analogues are regarded as the potent trienones for anti-oral cancer study. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2839 / 2844
页数:6
相关论文
共 29 条
[21]   Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents [J].
Ohtsu, H ;
Xiao, ZY ;
Ishida, J ;
Nagai, M ;
Wang, HK ;
Itokawa, H ;
Su, CY ;
Shih, C ;
Chiang, TY ;
Chang, E ;
Lee, YF ;
Tsai, MY ;
Chang, CS ;
Lee, KH .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) :5037-5042
[22]   Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB kinase and NFκB activation in macrophages [J].
Pan, MH ;
Lin-Shiau, SY ;
Lin, JK .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (11) :1665-1676
[23]   Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult:: A drug discovery effort against Alzheimer's disease [J].
Park, SY ;
Kim, DSHL .
JOURNAL OF NATURAL PRODUCTS, 2002, 65 (09) :1227-1231
[24]   Systemic treatment and medical management of metastatic squamous cell carcinoma of the head and neck: Review of the literature and proposal for management changes [J].
Peyrade, Frederic ;
Cupissol, Didier ;
Geoffrois, Lionel ;
Rolland, Frederic ;
Borel, Christian ;
Ciais, Catherine ;
Faivre, Sandrine ;
Guigay, Joel .
ORAL ONCOLOGY, 2013, 49 (06) :482-491
[25]   ANTITUMOR AND ANTIOXIDANT ACTIVITY OF NATURAL CURCUMINOIDS [J].
RUBY, AJ ;
KUTTAN, G ;
BABU, KD ;
RAJASEKHARAN, KN ;
KUTTAN, R .
CANCER LETTERS, 1995, 94 (01) :79-83
[26]   Total synthesis and structural revision of engelhardione [J].
Shen, Li ;
Sun, Dianqing .
TETRAHEDRON LETTERS, 2011, 52 (35) :4570-4574
[27]   Cancer Statistics, 2012 [J].
Siegel, Rebecca ;
Naishadham, Deepa ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2012, 62 (01) :10-29
[28]   Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo [J].
Thapliyal, R ;
Maru, GB .
FOOD AND CHEMICAL TOXICOLOGY, 2001, 39 (06) :541-547
[29]   Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck [J].
Vermorken, J. B. ;
Licitra, L. ;
Stoehlmacher-Williams, J. ;
Dietz, A. ;
Lopez-Picazo, J. M. ;
Hamid, O. ;
Hossain, A. M. ;
Chang, S. -C. ;
Gauler, T. C. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (13) :2877-2883